IMRT/IGRT Benefits


Recognized by many specialists as the greatest advancement in the treatment of prostate cancer in recent years, Intensity Modulated Radiation Therapy (IMRT) is being used with extraordinary skill to achieve extraordinary results at the Prostate Cancer Center.

The goal of IMRT is to improve the accuracy of carefully targeted radiation, thereby reducing the exposure of healthy tissue during each patient’s course of treatment.

Historically, during prostate cancer treatment, there were many factors that could contribute to differences between a planned dose and a delivered dose of radiation. One critical factor was, and still remains, the uncertainty with which patients are positioned on the treatment unit itself. For this reason, IGRT (image guided radiation therapy) is used before each treatment to assure accurate localization of the targeted prostate.

Thankfully, because IMRT uses imaging coordinates to guide its radiation beam within millimeters of the prescribed target, PCC’s experienced doctors and technologists are able to ensure that each patient is properly aligned for each one of their treatment sessions.

And because our doctors use this procedure every day, they have become proficient at retrieving maximum benefit from this remarkable technology.

With IMRT’s ability to localize treatment as never before, our doctors can increase the dose of radiation directly to the tumor without adversely affecting the surrounding healthy tissue. And because the IMRT beam can be manipulated, our specialists have become highly skilled at shaping the beam to approximate the shape of the prostate gland.

This precision is critical to the immediate and long-term consequences and potential benefits for each patient. The more targeted the treatment, and the less damage there is to surrounding tissue, the better the chances there are for a complete recovery.


  • One in seven men is at risk of being diagnosed with Prostate Cancer.
  • The average age of men diagnosed with prostate cancer is 72.
  • Over 75% of prostate cancer patients can expect to live at least five years from the time of diagnosis.
  • For men with prostate cancer that has not spread, only 1% will die from their prostate cancer within five years.